MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    The non-motor side of the honey-moon period of Parkinson’s disease

    R. Erro, M. Picillo, C. Vitale, M. Amboni, M. Moccia, M.T. Pellecchia, P. Barone (London, United Kingdom)

    Objective: To explore the non-motor side of the honey-moon period in Parkinson's disease (PD) and its impact on quality of life (QoL). Background: Although there…
  • 2016 International Congress

    P100 latency of pattern reversal visual evoked potential and visual hallucination in Parkinson’s disease

    M. Kohsaka, T. Oeda, A. Umemura, S. Tomita, K. Park, K. Yamamoto, H. Sugiyama, H. Sawada (Kyoto, Japan)

    Objective: To investigate whether P100 latency of pattern reversal visual evoked potential (PR-VEP) can predict the development of visual hallucination (VH) in Parkinson's disease (PD).…
  • 2016 International Congress

    Impulse control disorders after STN DBS for Parkinson’s disease

    P.G. Frederic, P. Camille, J. Nicolas, S. Abbas, F. Maria, P. Michel (Montreal, QC, Canada)

    Objective: To evaluate the prevalence and severity of impulse control disorders (ICD) and other impulsive-compulsive behaviors (ICB) in a cohort of patients with Parkinson's disease…
  • 2016 International Congress

    Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease. PPMI cohort

    T. Simuni, D. Weintraub, C. Caspell-Garcia, M. Walker, C.S. Coffey, S. Lasch, C. Tanner, D. Jennings, K. Kieburtz, K. Marek, On behalf of the PPMI Investigators (Chicago, IL, USA)

    Objective: To examine baseline prevalence and longitudinal change in non-motor symptoms (NMS) in a cohort of de novo (at baseline) Parkinson's disease (PD) patients compared…
  • 2016 International Congress

    Frequency and factors associated with neuropathic pain in patients with Parkinson’s disease

    J.F. Pascacio-Astudillo, A.L. Bazàn-Rodrìguez, M. Rodrìguez-Violante, A. Cervantes-Arriaga (Mèxico City, Mexico)

    Objective: To determine the prevalence of neuropathic pain in PD and association between neuropathic pain, duration of PD, treatment with Levodopa, cumulative dose, non-motor symptoms…
  • 2016 International Congress

    The National Parkinson Foundation mentoring and networking program: Phase I the process

    C.B. Hunter, P.R. Palmentera, B. Vernon, A. Silver, K. Arney, J. Fleisher, F. Cubillos (Houston, TX, USA)

    Objective: The National Parkinson Foundation (NPF) has focused on meeting the needs in the care and treatment of Parkinson's disease (PD). Through the Centers of…
  • 2016 International Congress

    Prevalence of Parkinson’s disease in Ukraine

    Y.O. Trufanov, N.K. Svyrydova, A.I. Galusha, G.M. Chupryna, O.V. Popov, M.V. Nechkalyuk (Kyiv, Ukraine)

    Objective: To compare the prevalence of Parkinson's disease (PD) in Ukraine in 2010 and 2014; to compare the prevalence of PD in Ukraine with other…
  • 2016 International Congress

    Long-term incidence of Parkinson’s disease in rural areas of Finland

    J. Isotalo, T. Vahlberg, V. Kaasinen (Turku, Finland)

    Objective: To investigate possible long-term changes in the incidence of Parkinson's disease (PD) in rural regions. Background: Living in rural areas has long been suspected…
  • 2016 International Congress

    Physical therapy practice variability and outcomes for people with Parkinson’s disease: Data from the National Parkinson Foundation quality improvement initiative (NPF-QII)

    M.R. Rafferty, P.N. Schmidt, S.T. Luo, K. Li, F. Cubillos, C. Marras, T. Davis, E.C. Nelson, T. Simuni (Chicago, IL, USA)

    Objective: To (1) describe current variability in physical therapy (PT) use by people with Parkinson's disease (PD) and to (2) examine the association between PT…
  • 2016 International Congress

    Effectiveness of occupational therapy multi-domain group therapy program for Parkinson’s disease

    R.K.M. Wong, D.S.W. Tsang, C.K.Y. Lau, A.Y.Y. Chan, D.T.M. Chan, X. Zhu, W. Poon, V.C.T. Mok (Hong Kong, Hong Kong)

    Objective: This pilot study investigated the effectiveness of an Occupational Therapy (OT) multi-domain group program on preventing fall, improving non-motor symptoms & reducing carers' stress…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley